Welcome to the College of Veterinary Medicine at the University of Illinois

Small Animal Services

Oncology, Medical and Radiation

Appointment Times

New Referrals: 10:30 to 11:30 a.m., Monday, Tuesday, Thursday, Friday

Chemotherapy: drop-off between 7:30 and 10:00 a.m., Monday through Friday

Patient Reevaluations: appointments between 9:45 and 10:15 a.m., Monday through Thursday

Clinical Trial Appointments: 9:45 to 10:45 a.m., Monday through Thursday

For consultations or appointments, contact:

Nancy George, LVT, Chief Clinical Case Coordinator, 217-244-7789



  • Complete clinical staging and diagnosis of common tumor types affecting dogs and cats including the use of advanced imaging modalities such as spiral computed tomography and ultrasonography.
  • Client education regarding treatment choices including surgical resection, systemic chemotherapy, immunotherapy (melanoma vaccine), radiation therapy, and novel targeted therapies for the management of tumor-bearing companion animals.

Special Capabilities

  • Cooperating with the National Cancer Institute to evaluate novel anticancer drugs to treat tumor-bearing dogs
  • Active clinical and basic research programs focused on cancer biology and discovery of novel agents to treat tumor-bearing dogs and cats
  • Advanced radiological equipment to assess bone health
  • Computerized pressure-sensing gait analysis equipment to evaluate pain in dogs with appendicular osteosarcoma


Sarah C. CharneySarah C. Charney, DVM, DACVIM (Oncology, Internal Medicine), DACVR (Radiation Oncology) • Clinical trials of new chemotherapy agents and protocols, as well as therapies for metastatic cancer.

Timothy M. FanTimothy M. Fan, DVM, PhD, DACVIM (Oncology, Internal Medicine) • Investigating novel therapies for slowing cancer-induced bone destruction and associated pain syndromes, with a primary emphasis in providing better therapies for alleviating discomfort caused by canine osteosarcoma.

Laura D. GarrettLaura D. Garrett, DVM, DACVIM (Oncology) • Investigating small molecules which selectively promote cancer cell death with a primary interest in improving response rates and survival times in dogs diagnosed with multicentric lymphoma.

Jackie WypijJackie Wypij, DVM • Investigation of cancer at the molecular level and bridging the gap between basic science research and clincial application for pets.

Additional Staff

Virginia CoyleVirginia Coyle, Resident

Jackie WypijPamela Lucas, Resident

  • Rachel Sternberg, Resident
  • Nancy George, CVT
  • Rebecca Kamerer, CVT
  • Jennifer Rose, CVT